[重组2020-2023年墨西哥COVID-19疫苗安全委员会,2020-2023年墨西哥]。

IF 2 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Ana María Santibañez Copado, G Reyes Terán, Sergio Iván Váldes Fererr, Noris Pavía Ruz S, Arauz Antonio, Carmen Toledo Salinas, Juan Luis Mosqueda, Patricio Ortiz Fernández, Jesús Alberto Espinosa-Santibañez, Selma Scheffler-Mendoza, José Luis Díaz Ortega, Nadia María Romualdo-Tello
{"title":"[重组2020-2023年墨西哥COVID-19疫苗安全委员会,2020-2023年墨西哥]。","authors":"Ana María Santibañez Copado, G Reyes Terán, Sergio Iván Váldes Fererr, Noris Pavía Ruz S, Arauz Antonio, Carmen Toledo Salinas, Juan Luis Mosqueda, Patricio Ortiz Fernández, Jesús Alberto Espinosa-Santibañez, Selma Scheffler-Mendoza, José Luis Díaz Ortega, Nadia María Romualdo-Tello","doi":"10.26633/RPSP.2024.106","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To describe the process of restructuring the National Expert Committee and its impact on the causality assessment of events supposedly attributable to vaccination or immunization (ESAVI) in the context of vaccine safety monitoring during the COVID-19 pandemic, 2020-2023.</p><p><strong>Method: </strong>A report was prepared on the experience of creating and operating Mexico's National Expert Committee during the aforementioned period.</p><p><strong>Results: </strong>During the 2020-2023 period, 1293 severe ESAVIs were reported after COVID-19 vaccination; after 98.6% (1275) of them had been assessed and classified, 10 specialized subcommittees were formed.</p><p><strong>Conclusions: </strong>Restructuring of the committee, assessment of adverse events with a series of prior steps, and use of the World Health Organization's causality assessment tool made it possible to generate scientific documents to validate vaccine safety and maintain trust in vaccination.</p>","PeriodicalId":21264,"journal":{"name":"Revista Panamericana De Salud Publica-pan American Journal of Public Health","volume":"48 ","pages":"e106"},"PeriodicalIF":2.0000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11653959/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Restructuring of the COVID-19 Vaccine Safety Committee 2020-2023 in MexicoReestruturação do Comitê para Segurança das Vacinas contra a COVID-19, 2020-2023, México].\",\"authors\":\"Ana María Santibañez Copado, G Reyes Terán, Sergio Iván Váldes Fererr, Noris Pavía Ruz S, Arauz Antonio, Carmen Toledo Salinas, Juan Luis Mosqueda, Patricio Ortiz Fernández, Jesús Alberto Espinosa-Santibañez, Selma Scheffler-Mendoza, José Luis Díaz Ortega, Nadia María Romualdo-Tello\",\"doi\":\"10.26633/RPSP.2024.106\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To describe the process of restructuring the National Expert Committee and its impact on the causality assessment of events supposedly attributable to vaccination or immunization (ESAVI) in the context of vaccine safety monitoring during the COVID-19 pandemic, 2020-2023.</p><p><strong>Method: </strong>A report was prepared on the experience of creating and operating Mexico's National Expert Committee during the aforementioned period.</p><p><strong>Results: </strong>During the 2020-2023 period, 1293 severe ESAVIs were reported after COVID-19 vaccination; after 98.6% (1275) of them had been assessed and classified, 10 specialized subcommittees were formed.</p><p><strong>Conclusions: </strong>Restructuring of the committee, assessment of adverse events with a series of prior steps, and use of the World Health Organization's causality assessment tool made it possible to generate scientific documents to validate vaccine safety and maintain trust in vaccination.</p>\",\"PeriodicalId\":21264,\"journal\":{\"name\":\"Revista Panamericana De Salud Publica-pan American Journal of Public Health\",\"volume\":\"48 \",\"pages\":\"e106\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-12-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11653959/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Panamericana De Salud Publica-pan American Journal of Public Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26633/RPSP.2024.106\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Panamericana De Salud Publica-pan American Journal of Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26633/RPSP.2024.106","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

目的:描述2020-2023年COVID-19大流行期间疫苗安全监测背景下,国家专家委员会重组过程及其对疫苗接种或免疫事件因果关系评估(ESAVI)的影响。方法:编写了一份关于在上述期间建立和运作墨西哥国家专家委员会的经验的报告。结果:2020-2023年期间,COVID-19疫苗接种后报告重症ESAVIs 1293例;在对其中的98.6%(1275件)进行评估和分类后,成立了10个专门小组委员会。结论:委员会的重组,不良事件的一系列预先评估,以及使用世界卫生组织的因果关系评估工具,使得有可能产生科学文件来验证疫苗的安全性,并保持对疫苗接种的信任。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Restructuring of the COVID-19 Vaccine Safety Committee 2020-2023 in MexicoReestruturação do Comitê para Segurança das Vacinas contra a COVID-19, 2020-2023, México].

Objective: To describe the process of restructuring the National Expert Committee and its impact on the causality assessment of events supposedly attributable to vaccination or immunization (ESAVI) in the context of vaccine safety monitoring during the COVID-19 pandemic, 2020-2023.

Method: A report was prepared on the experience of creating and operating Mexico's National Expert Committee during the aforementioned period.

Results: During the 2020-2023 period, 1293 severe ESAVIs were reported after COVID-19 vaccination; after 98.6% (1275) of them had been assessed and classified, 10 specialized subcommittees were formed.

Conclusions: Restructuring of the committee, assessment of adverse events with a series of prior steps, and use of the World Health Organization's causality assessment tool made it possible to generate scientific documents to validate vaccine safety and maintain trust in vaccination.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.10
自引率
3.80%
发文量
222
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信